Literature DB >> 20426775

Filaggrin null mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study.

J P Thyssen1, B C Carlsen, T Menné, A Linneberg, N H Nielsen, M Meldgaard, P B Szecsi, S Stender, J D Johansen.   

Abstract

BACKGROUND: Hand eczema is prevalent in the general population. It remains unclear whether or not filaggrin gene (FLG) null mutations increase the overall risk of hand eczema or only increase the risk of hand eczema in subjects with atopic dermatitis.
OBJECTIVES: To investigate the association between FLG null mutations and hand eczema.
METHODS: A random sample of 3335 adults from the general population in Denmark was patch tested, FLG genotyped for R501X and 2282del4 null mutations and questioned about hand eczema.
RESULTS: Participants with combined presence of atopic dermatitis and FLG null mutation status had a significantly higher prevalence of hand eczema, an earlier onset of hand eczema and a higher persistence of hand eczema compared with subjects with normal FLG status and absence of atopic dermatitis. Logistic regression analyses revealed positive associations between hand eczema within the past 12 months and FLG null mutation status in participants with a history of atopic dermatitis [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.27-7.01], but not in subjects without atopic dermatitis (OR 0.82; 95% CI 0.41-1.67).
CONCLUSIONS: FLG null mutations were significantly associated with hand eczema (< 12 months) in subjects with atopic dermatitis. Combined atopic dermatitis and filaggrin null mutation status was strongly associated with early onset of hand eczema and hand eczema persistence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426775     DOI: 10.1111/j.1365-2133.2010.09822.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Advances in atopic dermatitis.

Authors:  Natalija Novak; Donald Y M Leung
Journal:  Curr Opin Immunol       Date:  2011-10-19       Impact factor: 7.486

2.  Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.

Authors:  Charlotte Giwercman Carson; Morten Arendt Rasmussen; Jacob P Thyssen; Torkil Menné; Hans Bisgaard
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

Review 3.  One remarkable molecule: filaggrin.

Authors:  Sara J Brown; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

4.  Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial.

Authors:  Isabelle L Smith; Rachael Gilberts; Sarah Brown; Catherine Fernandez; Jane Nixon; Catherine Reynolds; Catherine Smith; John T Lear; Lesley Sunderland; Cathy Green; Mark Goodfield; Fiona Cowdell; Philip Hampton; Amy Barker; Armando Vargas-Palacios; Sandy Tubeuf; Miriam Wittmann
Journal:  BMJ Open       Date:  2022-02-23       Impact factor: 2.692

Review 5.  Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics.

Authors:  A L Bosma; A Ascott; R Iskandar; K Farquhar; J Matthewman; M W Langendam; A Mulick; K Abuabara; H C Williams; P I Spuls; S M Langan; M A Middelkamp-Hup
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-02-25       Impact factor: 9.228

6.  Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis.

Authors:  M J Visser; L Landeck; L E Campbell; W H I McLean; S Weidinger; F Calkoen; S M John; S Kezic
Journal:  Br J Dermatol       Date:  2013-02       Impact factor: 9.302

7.  Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study.

Authors:  Maaike J Visser; Maarten M Verberk; Linda E Campbell; W H Irwin McLean; Florentine Calkoen; Jan G Bakker; Frank J H van Dijk; Jan D Bos; Sanja Kezic
Journal:  Contact Dermatitis       Date:  2013-09-19       Impact factor: 6.600

Review 8.  Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?

Authors:  Neide Kalil Gaspar; Márcia Kalil Aidé
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

Review 9.  Hand Dermatitis: A Comprehensive Review with Special Emphasis on COVID-19 Pandemic.

Authors:  Ziaul Haque Ahmed; Komal Agarwal; Rashmi Sarkar
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.